Harrow B, Fagnani F, Nevoret C et al (2022) Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
For inflammatory bowel disease, ulcers, and gut-permeability issues, we'll use oral BPC-157 sometimes alongside injections
For a detailed overview of Australian research-compound regulation, see our guide to peptide legality and TGA compliance in Australia
What Does BPC 157 capsule Cost in Australia
The prospective study that followed 4,007 individuals with or without cardiovascular disease for a three-year period found baseline concentrations of circulating TMAO to be positively correlated with incidence of death, nonfatal myocardial infarction, and stroke described as major adverse cardiac events (MACE) (23)